
Senseonics Holdings, Inc. – AMEX:SENS
Senseonics Holdings stock price today
Senseonics Holdings stock price monthly change
Senseonics Holdings stock price quarterly change
Senseonics Holdings stock price yearly change
Senseonics Holdings key metrics
Market Cap | 277.89M |
Enterprise value | 301.31M |
P/E | -6 |
EV/Sales | 13.34 |
EV/EBITDA | 0.83 |
Price/Sales | 12.43 |
Price/Book | 7.45 |
PEG ratio | -0.04 |
EPS | -0.13 |
Revenue | 23.29M |
EBITDA | -70.16M |
Income | -80.59M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 1474.8% |
Oper. margin | -446.44% |
Gross margin | 18.05% |
EBIT margin | -446.44% |
EBITDA margin | -301.12% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSenseonics Holdings stock price history
Senseonics Holdings stock forecast
Senseonics Holdings financial statements
Jun 2023 | 4.12M | -20.42M | -494.98% |
---|---|---|---|
Sep 2023 | 6.09M | -24.10M | -395.33% |
Dec 2023 | 8.02M | -17.19M | -214.07% |
Mar 2024 | 5.04M | -18.87M | -374.02% |
Sep 2025 | 10.33M | -18.56M | -179.65% |
---|---|---|---|
Oct 2025 | 9.87M | -18.43M | -186.71% |
Dec 2025 | 12.66M | -18.43M | -145.64% |
Mar 2026 | 10.57M | -16.07M | -152.01% |
Analysts Price target
Financials & Ratios estimates
Dec 2022 | 177673000 | 180.24M | 101.45% |
---|---|---|---|
Sep 2023 | 154065000 | 102M | 66.21% |
Dec 2023 | 138220000 | 64.76M | 46.86% |
Mar 2024 | 126516000 | 69.89M | 55.25% |
Jun 2023 | -17.98M | -4.07M | 5.52M |
---|---|---|---|
Sep 2023 | -17.26M | 27.64M | 16.82M |
Dec 2023 | -14.82M | 36.19M | -1.42M |
Mar 2024 | -20.26M | 25.37M | 10.03M |
Senseonics Holdings alternative data
Jan 2025 | 0 |
---|---|
Feb 2025 | 0 |
May 2025 | 2 |
Jul 2025 | 0 |
Aug 2025 | 0 |
Aug 2023 | 121 |
---|---|
Sep 2023 | 121 |
Oct 2023 | 121 |
Nov 2023 | 121 |
Dec 2023 | 121 |
Jan 2024 | 121 |
Feb 2024 | 121 |
Mar 2024 | 132 |
Apr 2024 | 132 |
May 2024 | 132 |
Jun 2024 | 132 |
Jul 2024 | 132 |
Senseonics Holdings other data
Period | Buy | Sel |
---|---|---|
Dec 2024 | 764933 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | ROEDER DOUGLAS A director | Common Stock | 25,000 | $0.5 | $12,500 | ||
Purchase | SULLIVAN FREDERICK T. officer: Chief Financial Officer | Common Stock | 124,933 | $0.38 | $47,475 | ||
Purchase | ROEDER DOUGLAS A director | Common Stock | 300,000 | $0.41 | $123,000 | ||
Purchase | GOODNOW TIMOTHY T director, officer.. | Common Stock | 315,000 | $0.31 | $97,650 | ||
Sale | LARKIN SHARON director | Common Stock | 30,889 | $0.61 | $18,842 | ||
Purchase | ROEDER DOUGLAS A director | Common Stock | 300,000 | $0.54 | $162,000 | ||
Purchase | PHC HOLDINGS CORP | Warrant to purchase Common Stock | 1 | $0 | $0 | ||
Sale | JAIN MUKUL officer: Chief Op.. | Common Stock | 50,000 | $1.97 | $98,500 | ||
Option | FIORENTINO EDWARD director | Stock Option (right to buy) | 83,900 | $0.54 | $45,306 | ||
Sale | FIORENTINO EDWARD director | Common Stock | 63,553 | $1.65 | $104,862 |
Quarter | Transcript |
---|---|
Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 29 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Inotiv: High Expenses Likely To Impair Long-Term Profitability
Senseonics Holdings: Planning To Increase Revenue After FDA System Approval
Senseonics: Shares Primed For 180-Day Approval
Senseonics Holdings: Will Not Fail For Lack Of Intent
Senseonics: On The Cusp Of Rapid Growth
PAVmed: A True Game-Changer For Medical Device Innovation
1847 Goedeker: An Under The Radar Potential Multibagger
-
What's the price of Senseonics Holdings stock today?
One share of Senseonics Holdings stock can currently be purchased for approximately $0.46.
-
When is Senseonics Holdings's next earnings date?
Unfortunately, Senseonics Holdings's (SENS) next earnings date is currently unknown.
-
Does Senseonics Holdings pay dividends?
No, Senseonics Holdings does not pay dividends.
-
How much money does Senseonics Holdings make?
Senseonics Holdings has a market capitalization of 277.89M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 36.62% to 22.39M US dollars.
-
What is Senseonics Holdings's stock symbol?
Senseonics Holdings, Inc. is traded on the AMEX under the ticker symbol "SENS".
-
What is Senseonics Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Senseonics Holdings?
Shares of Senseonics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Senseonics Holdings's key executives?
Senseonics Holdings's management team includes the following people:
- Dr. Timothy T. Goodnow Pres, Chief Executive Officer & Director(age: 63, pay: $1,050,000)
- Dr. Francine Ratner Kaufman M.D. Chief Medical Officer & Director(age: 74, pay: $739,490)
- Dr. Mukul Jain Chief Operating Officer(age: 52, pay: $619,150)
-
How many employees does Senseonics Holdings have?
As Jul 2024, Senseonics Holdings employs 132 workers.
-
When Senseonics Holdings went public?
Senseonics Holdings, Inc. is publicly traded company for more then 9 years since IPO on 22 Dec 2015.
-
What is Senseonics Holdings's official website?
The official website for Senseonics Holdings is senseonics.com.
-
Where are Senseonics Holdings's headquarters?
Senseonics Holdings is headquartered at 20451 Seneca Meadows Parkway, Germantown, MD.
-
How can i contact Senseonics Holdings?
Senseonics Holdings's mailing address is 20451 Seneca Meadows Parkway, Germantown, MD and company can be reached via phone at +30 15157260.
Senseonics Holdings company profile:

Senseonics Holdings, Inc.
senseonics.comAMEX
132
Medical - Devices
Healthcare
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Germantown, MD 20876-7005
CIK: 0001616543
ISIN: US81727U1051
CUSIP: 81727U105